104 related articles for article (PubMed ID: 8883872)
1. The neuroprotective efficacy of MK-801 in focal cerebral ischemia varies with rat strain and vendor.
Oliff HS; Marek P; Miyazaki B; Weber E
Brain Res; 1996 Aug; 731(1-2):208-12. PubMed ID: 8883872
[TBL] [Abstract][Full Text] [Related]
2. Infarct volume varies with rat strain and vendor in focal cerebral ischemia induced by transcranial middle cerebral artery occlusion.
Oliff HS; Weber E; Miyazaki B; Marek P
Brain Res; 1995 Nov; 699(2):329-31. PubMed ID: 8616638
[TBL] [Abstract][Full Text] [Related]
3. The role of strain/vendor differences on the outcome of focal ischemia induced by intraluminal middle cerebral artery occlusion in the rat.
Oliff HS; Weber E; Eilon G; Marek P
Brain Res; 1995 Mar; 675(1-2):20-6. PubMed ID: 7796130
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective and behavioral effects of the selective metabotropic glutamate mGlu(1) receptor antagonist BAY 36-7620.
De Vry J; Horváth E; Schreiber R
Eur J Pharmacol; 2001 Oct; 428(2):203-14. PubMed ID: 11675037
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective properties of the novel antiepileptic drug levetiracetam in the rat middle cerebral artery occlusion model of focal cerebral ischemia.
Hanon E; Klitgaard H
Seizure; 2001 Jun; 10(4):287-93. PubMed ID: 11466025
[TBL] [Abstract][Full Text] [Related]
6. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
7. The time course of glucose metabolism in rat cerebral ischemia with middle cerebral artery occlusion-reperfusion model and the effect of MK-801.
Liu Y; Mituska S; Hashizume K; Hosaka T; Nukui H
Neurol Res; 1996 Dec; 18(6):505-8. PubMed ID: 8985950
[TBL] [Abstract][Full Text] [Related]
8. The neuroprotective action of dizocilpine (MK-801) in the rat middle cerebral artery occlusion model of focal ischaemia.
Gill R; Brazell C; Woodruff GN; Kemp JA
Br J Pharmacol; 1991 Aug; 103(4):2030-6. PubMed ID: 1912992
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia nullifies the ameliorating effect of dizocilpine maleate (MK-801) in focal cerebral ischemia.
Memezawa H; Zhao Q; Smith ML; Siesjö BK
Brain Res; 1995 Jan; 670(1):48-52. PubMed ID: 7719723
[TBL] [Abstract][Full Text] [Related]
10. Is MK-801 neuroprotection mediated by systemic hypothermia in the immature rat?
Gilland E; Hagberg H
Neuroreport; 1997 May; 8(7):1603-5. PubMed ID: 9189899
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotection by Combined Administration with Maslinic Acid, a Natural Product from Olea europaea, and MK-801 in the Cerebral Ischemia Model.
Qian Y; Tang X; Guan T; Li Y; Sun H
Molecules; 2016 Aug; 21(8):. PubMed ID: 27548129
[TBL] [Abstract][Full Text] [Related]
12. Selective mGluR5 receptor antagonist or agonist provides neuroprotection in a rat model of focal cerebral ischemia.
Bao WL; Williams AJ; Faden AI; Tortella FC
Brain Res; 2001 Dec; 922(2):173-9. PubMed ID: 11743947
[TBL] [Abstract][Full Text] [Related]
13. MK 801 and dexamethasone reduce both tumor necrosis factor levels and infarct volume after focal cerebral ischemia in the rat brain.
Bertorelli R; Adami M; Di Santo E; Ghezzi P
Neurosci Lett; 1998 Apr; 246(1):41-4. PubMed ID: 9622203
[TBL] [Abstract][Full Text] [Related]
14. NXY-059, a novel free radical trapping compound, reduces cortical infarction after permanent focal cerebral ischemia in the rat.
Zhao Z; Cheng M; Maples KR; Ma JY; Buchan AM
Brain Res; 2001 Aug; 909(1-2):46-50. PubMed ID: 11478919
[TBL] [Abstract][Full Text] [Related]
15. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
Graham SH; Chen J; Lan JQ; Simon RP
J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective effect of the novel noncompetitive NMDA antagonist, FR115427 in focal cerebral ischemia in rats.
Katsuta K; Nakanishi H; Shirakawa K; Yoshida K; Takagi K; Tamura A
J Cereb Blood Flow Metab; 1995 Mar; 15(2):345-8. PubMed ID: 7860668
[TBL] [Abstract][Full Text] [Related]
17. Effects of RSR13, a synthetic allosteric modifier of hemoglobin, alone and in combination with dizocilpine, on outcome from transient focal cerebral ischemia in the rat.
Sarraf-Yazdi S; Sheng H; Grocott HP; Bart RD; Pearlstein RD; Steffen RP; Warner DS
Brain Res; 1999 May; 826(2):172-80. PubMed ID: 10224294
[TBL] [Abstract][Full Text] [Related]
18. Infarct tolerance induced by intra-cerebral infusion of recombinant brain-derived neurotrophic factor.
Yanamoto H; Nagata I; Sakata M; Zhang Z; Tohnai N; Sakai H; Kikuchi H
Brain Res; 2000 Mar; 859(2):240-8. PubMed ID: 10719070
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective effects of MK-801 in different rat stroke models for permanent middle cerebral artery occlusion: adverse effects of hypothalamic damage and strategies for its avoidance.
Gerriets T; Stolz E; Walberer M; Kaps M; Bachmann G; Fisher M
Stroke; 2003 Sep; 34(9):2234-9. PubMed ID: 12920258
[TBL] [Abstract][Full Text] [Related]
20. The competitive NMDA receptor antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischemia.
Sauer D; Allegrini PR; Fagg GE
J Neural Transm Suppl; 1994; 43():81-9. PubMed ID: 7884410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
